您好,欢迎来到上海士研管理咨询有限公司
产业峰会 活动服务 营销服务 专家服务
  • 产业峰会:
    以专业团队对产业和市场客观详实地调研为前提,拥有战略性、系统性、全球性的基因,汇集了领导者关注的热点话题与领袖代表,为您提供“一站式”的对话、分享、社交平台!
  • 活动服务:
    致力于成为全球最专业的产业峰会活动提供商,为企业和机构的产业性峰会活动提供一站式专业服务,从调研策划到定制邀请、从营销推广到运营组织,还有项目管理,每项服务都由经验丰富的专业团队匹配长期沉淀的产业资源予以卓越执行,我们注重建立长期而深入的伙伴关系。
  • 营销服务:
    致力于成为全球领先的2B营销服务机构,聚焦产业高端活动、内容、渠道的建设与沉淀,为客户提供一站式整合营销解决方案,助力企业线上线下获客与品牌筑造。我们深信专业团队匹配产业资源带来卓越执行,我们注重建立长期而深入的伙伴关系。
  • 专家服务:
    中国领先的行业专家知识信息服务供应商,为需要专业洞见的商业决策者匹配具有一手经验的行业专家,助力他们以更加明确的目标和坚定的信心做出决策。我们有60万余名专家顾问遍布一百二十多个行业,而且每天还在增加。
会议赞助商
19
2022 - 03 - 08
点击次数:
北京万慧达知识产权代理有限公司创立于1999年,北京市万慧达律师事务所创立于2003年。——总部坐落在北京,并在中国上海、广州、深圳、香港、宁波、苏州、杭州、天津、重庆等地设有办公机构。——专业团队450+人,合伙人40+人,专业律师、专利代理人、商标代理人等中坚力量260+人。——服务于遍布全球的数千客户,业务覆盖知识产权法律服务的全部范畴,在专利、商标、版权、保护及诉讼等各分支领域均居行业领跑梯队。专业上、地域上的平台优势,使工作团队可以最大化地共享资源,为客户提供全方位一体化的知识产权法律服务。万慧达知识产权,专业创造可能,沟通成就品质!Wanhuida Intellectual Property is a leading IP service provider in China. It has two main legal entities, Wanhuida IP Agency and Wanhuida Law Firm, and has offices in Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Hong Kong, Suzhou, Ningbo, Tianjin and Chongqing, covering all major IP hubs in China.Wanhuida is now home for some 450 employees working exclusively in the field of intellectual property. We have some 120 IP lawyers specialized in IP litigation and enforcement work, 90 trademark attorneys, 70 patent attorneys and other professionals, including investigators and supporting staff. Many of them are recognized leaders in their respective fields. They have a wide range of experiences from private practice, in-house counseling, to government services in courts, police departments and administrative agencies.We serve clients worldwide, China, Europe, the United States, Japan, Korea and other countries. Our clients spread across a broad spectrum of industries, consumer goods, chemical, pharmaceutical, biotech, mechanical, electronics and telecommunications. Our clientele grows steadily over the years. Client trust is a hallmark of Wanhuida services. Their loyal business and generous referrals are the single most important factor contributing to our continued growth.
20
2022 - 03 - 08
点击次数:
国家级平湖经济技术开发区坐落于浙江东北部,于上海市一小时经济圈内,坐拥高速、高铁、国际机场与港口等区位优势和交通资源,已成为企业抢抓长三角地区一体化机遇的投资热土。近年来,平湖经济技术开发区主导培育了生物技术与医药产业园,主打医药开发、医疗器械、生命健康等新兴产业,代表企业有华谊集团、莎普爱思、正大集团、维通利华、泛亚医药等。Pinghu Economic-Technological Development Zone (PEDZ) is a national level development zone located in northeast of Zhejiang within one hour driving distance away from downtown Shanghai, and well connected with highways, CRH trains, international airports and habors. With the advantageous location, PEDZ has been one of the best choices for enterprises seizing business opportunities in the integration of Yangtze River Delta. In recent years PEDZ has successfully established and cultivated Biology Technology & Pharmaceutical Industry Park that focusing on new developing industries such as pharmaceutical development, medical instruments, and life health.The representative brands are Huayi, Shapuaisi Pharma, Chia Thai Group, Pan-Asia Pharma, etc..
21
2022 - 03 - 08
点击次数:
康体生命成立于2016年,为国家高新技术企业,为客户提供包括GPCR等靶点蛋白纳米抗体药物开发CRO服务。公司由长江学者杜洋教授领衔,技术团队由多位生物医药博士负责,组建有哺乳动物细胞、昆虫细胞、酵母、大肠杆菌等蛋白表达纯化平台,纳米抗体发现平台,抗体工程平台,质量分析平台等,为客户提供纳米抗体定制研发解决方案。康体生命拥有2000平米实验室及各种实验设备。纳米抗体开发团队免疫或筛选过的抗原或靶点包括但不限于Hpv16,Hpv18,Claudin18.2,Lilrb-2,Amyloid A,Procalcitonin,TAC2,PD-1,PD-L1,CTLA4,CD3(epsilon&gamma),Integrin,病毒样颗粒,AAV,IL-5.PCSK9,KLH偶联的各种多肽包括磷酸化多肽及乙酰化或甲基化多肽,KLH-HAKLH-Myc,KLH-Flag,GST,CD7,CD28,CD33,CD38,CD70,CD73,CD79,CD22,CD123,CD167, GRP78,Human RAGE,HSP70,HSP90,ROR1,IGF2R,IGFBP5,GPC3,SARS-CoV-2 S1包括Delta及Omicron RBD蛋白,EBV gHqL,KRAS,CXCL1,GUCY2C,hTPX2,Nectin4,Leptin,FGF R4,VEGFR2,VEGFR3,FAP,CEACAM5,PSMA,PSA,YAP,B7H7,TIGIT,VEGF A,IL-2R,Wnt2, 人载脂蛋白A-1,人载脂蛋白 B, 人血红蛋白,SERPINA3,人转铁蛋白,GFP.mCherry,鼠lgG,兔lgG及许多客户提供的不知名的靶点蛋白。除了蛋白抗原外,康体生命科技有限公司也用细胞,灭活病毒,病毒样颗粒,细胞膜碎片等对羊驼进行免疫。AlpaLife is a biotechnology company in China founded by scientists with strong background in antibody production and G-protein coupled receptors (GPCRs) drug discovery. Now we exclusively engage in development and production of customized well-performed and high-quality Alpaca nanobodies (single-domain antibodies or VHHs) for cytoplasmic proteins and membrane proteins (especially GPCRs) and related products for life-sciences, biotechnology and bio-medical research. Nanobodies are the emerging novel tools for both basic scientific research and clinical therapeutics.  They have unique properties including small size (~15 KD), high affinity, excellent solubility, superior stability, quick clearance from blood, and deep tissue penetration, which enables a wide range of applications such as affinity capture reagents, crystallization chaperones, target imaging and immunomodulation, biosensors, in vivo imaging, antivenom therapy and anti-infective agents.AlpaLife carries out nanobodies development through both Immune and non-Immune naïve and synthetic libraries. We have been working with multiple top pharmaceutical companies in China. Cooperated with laboratories in more than ten countries including U.S., Germany, South Korea, Thailand etc. Trying to provide the products with the best service, quality and reliability to the scientific community worldwide. Now we already have successful cases including human C-Reactive Protein nanobodies and 2019-Sars-Cov2 spike protein nanobodies, and we are collaborating with the Chinese University of Hong Kong in Shen Zhen for GPCR targeted nanobodies development. We offer one-stop solution from antigen preparation to selected nanobody purification and evolution. With extensive experience in custom single domain antibody development, we are ready to help simplify and accelerate your research by novel nanobodies.
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务